Cold Weather Flaring Up Your Perioral Dermatitis? This Is How To Tackle It
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
'Doctors said my son may have a milk allergy, weeks later he looked like a burns victim'
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
ophthalmologytimes4d
Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results
Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...
modernretina4d
Adverum Biotechnologies shares positive 52-week LUNA and 4-year OPTIC results
LUNA is an ongoing double-masked, randomized Phase 2 trial. OPTIC is an ongoing, open-label, dose-ranging first-in-human ...
gastroenterologyadvisor5d
Topical Corticosteroids Efficacious, Safe for Long-Term Eosinophilic Esophagitis
Topical corticosteroid treatment over 6 years is safe and efficacious for treating eosinophilic esophagitis. Long-term use of topical corticosteroids (tCS) is both safe and efficacious for treating ...
Too Old to Operate6d
Long-term Outcomes and Treatment Strategies for Nodular Vasculitis
Retrospective study of an uncommon disease in a non-tuberculosis endemic country with focus on treatment modalities and ...
Medscape7d
Topical Ivermectin Among Treatment Options for Ocular Rosacea
Symptoms of ocular rosacea may include only “a dry, gritty feel” to the eye and a red eyelid margin, according to ...
Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
LUNA data combined with follow-up from OPTIC at 4 years continue to support long-term potential best-in-class product profile of ...
verywellhealth10d
15 Expert-Backed Strategies for Hair Regrowth
Treatments for hair regrowth include medicated formulas, supplements, lasers, and complementary remedies, such as massage and ...
Arcutis Biotherapeutics: +200% On ZORYVE Approval, But When Is The Next Leg Up?
Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.
BBC15d
Woman shares 'ordeal' of steroid cream withdrawal
A Jersey woman has been sharing her experience of Topical Steroid Withdrawal (TSW) to raise awareness of the difficulties that can be faced. Elsie-May Baker has been using topical steroids since ...